Literature DB >> 7559937

Human Bordetella bronchiseptica infection related to contact with infected animals: persistence of bacteria in host.

P Gueirard1, C Weber, A Le Coustumier, N Guiso.   

Abstract

Within a period of 2 1/2 years, Bordetella bronchiseptica was isolated four times from a 79-year-old woman with bronchopneumonia. We have demonstrated by pulsed-field gel electrophoresis that this infection was related to contact with infected rabbits. The initial human B. bronchiseptica isolate had a phenotype characteristic of usual B. bronchiseptica clinical isolates; it produced toxin and adhesins, such as adenylate cyclase-hemolysin, filamentous hemagglutinin, and pertactin, and was able to induce lethality in a murine respiratory model. By contrast, although the three successive human isolates produced adhesins, they did not express adenylate cyclase-hemolysin and were unable to induce lethality. This implies that adenylate cyclase-hemolysin is required to induce lethality. We suggest that B. bronchiseptica may persist in the host, with expression of adenylate cyclase-hemolysin being essential for the initiation of infection and expression of adhesins being essential for persistence.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7559937      PMCID: PMC228324          DOI: 10.1128/jcm.33.8.2002-2006.1995

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  34 in total

1.  Bordetella parapertussis and Bordetella bronchiseptica contain transcriptionally silent pertussis toxin genes.

Authors:  B Aricò; R Rappuoli
Journal:  J Bacteriol       Date:  1987-06       Impact factor: 3.490

2.  A simple chemically defined medium for the production of phase I Bordetella pertussis.

Authors:  D W Stainer; M J Scholte
Journal:  J Gen Microbiol       Date:  1970-10

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Bordetella pertussis adenylate cyclase. Purification, characterization, and radioimmunoassay.

Authors:  D Ladant; C Brezin; J M Alonso; I Crenon; N Guiso
Journal:  J Biol Chem       Date:  1986-12-05       Impact factor: 5.157

5.  Bordetella bronchiseptica bacteremia.

Authors:  D A Katzenstein; L Ciofalo; M C Jordan
Journal:  West J Med       Date:  1984-01

Review 6.  Biology of Bordetella bronchiseptica.

Authors:  R A Goodnow
Journal:  Microbiol Rev       Date:  1980-12

7.  Phagocyte impotence caused by an invasive bacterial adenylate cyclase.

Authors:  D L Confer; J W Eaton
Journal:  Science       Date:  1982-09-03       Impact factor: 47.728

8.  Pathogenesis of canine bordetellosis.

Authors:  D A Bemis; H A Greisen; M J Appel
Journal:  J Infect Dis       Date:  1977-05       Impact factor: 5.226

9.  Genetic diversity and relationships in populations of Bordetella spp.

Authors:  J M Musser; E L Hewlett; M S Peppler; R K Selander
Journal:  J Bacteriol       Date:  1986-04       Impact factor: 3.490

10.  Bordetella bronchiseptica bronchitis.

Authors:  C J Papasian; N J Downs; R L Talley; D J Romberger; G R Hodges
Journal:  J Clin Microbiol       Date:  1987-03       Impact factor: 5.948

View more
  49 in total

1.  Restriction endonuclease analysis discriminates Bordetella bronchiseptica isolates.

Authors:  R E Sacco; K B Register; G E Nordholm
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

2.  Role of phosphoglucomutase of Bordetella bronchiseptica in lipopolysaccharide biosynthesis and virulence.

Authors:  N P West; H Jungnitz; J T Fitter; J D McArthur; C A Guzmán; M J Walker
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

3.  Pneumonia due to Bordetella bronchiseptica in a cystic fibrosis patient: 16S rRNA sequencing for diagnosis confirmation.

Authors:  Frédéric Wallet; Thierry Perez; Sylvie Armand; Benoit Wallaert; René J Courcol
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

4.  Bordetella bronchiseptica persists in the nasal cavities of mice and triggers early delivery of dendritic cells in the lymph nodes draining the lower and upper respiratory tract.

Authors:  Pascale Gueirard; Patrick Ave; Anne-Marie Balazuc; Sabine Thiberge; Michel Huerre; Genevieve Milon; Nicole Guiso
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

5.  Bordetella bronchiseptica in a paediatric cystic fibrosis patient: possible transmission from a household cat.

Authors:  K B Register; N Sukumar; E L Palavecino; B K Rubin; R Deora
Journal:  Zoonoses Public Health       Date:  2012-01-02       Impact factor: 2.702

6.  Prevalence and sequence variants of IS481 in Bordetella bronchiseptica: implications for IS481-based detection of Bordetella pertussis.

Authors:  Karen B Register; Gary N Sanden
Journal:  J Clin Microbiol       Date:  2006-10-25       Impact factor: 5.948

7.  Replacement of adenylate cyclase toxin in a lineage of Bordetella bronchiseptica.

Authors:  Anne M Buboltz; Tracy L Nicholson; Mylisa R Parette; Sara E Hester; Julian Parkhill; Eric T Harvill
Journal:  J Bacteriol       Date:  2008-06-13       Impact factor: 3.490

8.  The lipopolysaccharide of Bordetella bronchiseptica acts as a protective shield against antimicrobial peptides.

Authors:  A Banemann; H Deppisch; R Gross
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

Review 9.  Characteristics of Bordetella hinzii strains isolated from a cystic fibrosis patient over a 3-year period.

Authors:  G Funke; T Hess; A von Graevenitz; P Vandamme
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

10.  Cavitary pneumonia in an AIDS patient caused by an unusual Bordetella bronchiseptica variant producing reduced amounts of pertactin and other major antigens.

Authors:  Benito Lorenzo-Pajuelo; José Luis Villanueva; Juan Rodríguez-Cuesta; Nuria Vergara-Irigaray; Máximo Bernabeu-Wittel; Andrés Garcia-Curiel; Guillermo Martínez de Tejada
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.